NFKB1 and cervical cancer: Our finding is consistent with predecessor's studies and confirmed that ICA suppressed the tumor progression of cervical cancer by inhibiting TLR4/MyD88/NF-κB and Wnt/β-catenin pathways in vitro and in vivo.